Try our Advanced Search for more refined results

Ontario Teachers' Pension Plan Board, et al v. Teva Pharmaceutical Industries Ltd. et al

Track this case

Case overview

Case Number:

3:17-cv-00558

Court:

Connecticut

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Stefan R. Underhill

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 21, 2022

    The Largest Securities Settlements Announced In 2022

    From a billion-dollar deal in Delaware to a hard-fought battle over a bribery scandal involving Ohio's legislature, securities litigators secured big settlements this year that sprang from both class actions and derivative suits, with a high number of resolutions occurring in Delaware Chancery Court.

  2. January 27, 2022

    Teva Gets Nod For $420M Price-Fixing Deal With Investors

    A Connecticut federal judge granted preliminary approval to a $420 million deal resolving an investor class action accusing Teva Pharmaceuticals of orchestrating an industrywide price-fixing scheme, holding that the agreement is reasonable and there are no obvious red flags.

  3. January 18, 2022

    Teva Reaches $420M Deal To End Investors' Price-Fixing Suit

    Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to resolve an investor class action accusing the pharmaceutical giant of being at the center of an industrywide price-fixing scheme.

  4. March 09, 2021

    Teva Investors Win Class Cert. In Securities Suit

    A Connecticut federal court on Tuesday certified a class of Teva Pharmaceutical investors accusing the company of attributing its success to good business decisions when much of the good fortune was instead due to its participation in an allegedly sprawling generic drug price-fixing conspiracy.

  5. October 21, 2020

    DOJ Can Jump Into Teva Suit, But Only On Limited Basis

    A Connecticut federal judge said the U.S. Department of Justice can get involved in a price-fixing case against Teva Pharmaceuticals, but only so antitrust enforcers can explain how the litigation could impact their own probe of the generic-drug giant.

  6. October 01, 2020

    Shareholders Can't Fish Through Teva Texts, Judge Told

    Teva Pharmaceuticals urged a Connecticut federal judge Wednesday not to allow shareholders to embark on a "radical fishing expedition" through a slew of company text messages, arguing that the bid for data will only draw the securities fraud class action in the wrong direction.

  7. September 17, 2020

    Feds Want In On Private Price-Fix Suits Versus Teva

    The U.S government has urged a Connecticut federal judge to let it intervene in a private price-fixing case against Teva Pharmaceuticals, saying the case may bring to light information that could be useful in a federal probe of the generic-drug giant.

  8. July 09, 2020

    Teva Says Securities Claims Filed Too Late In Price-Fixing Suit

    Teva Pharmaceutical Industries Ltd. has urged a Connecticut federal court to toss securities fraud claims that it operated a price-fixing scheme and lied about profit growth, arguing that the allegations were brought too late.

  9. June 22, 2020

    Shareholders Seek Class Cert. In Teva Price-Fixing Suit

    Shareholders accusing Teva Pharmaceutical Industries Ltd. of operating a price-fixing scheme and lying about profit growth have asked a Connecticut federal judge to certify their proposed class, arguing that they easily meet all of the federal requirements.

  10. March 11, 2020

    21 Related Teva Price-Fixing Suits Consolidated

    A Connecticut federal judge streamlined widespread litigation accusing Teva Pharmaceutical Industries Ltd. of operating a price-fixing scheme and lying about profit growth by consolidating 21 similar suits against the drugmaker Tuesday.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!